| # | Drug | Count |
|---|---|---|
| 0 | LENVATINIB | 50 |
| 1 | SORAFENIB | 44 |
| 2 | BEVACIZUMAB | 36 |
| 3 | DURVALUMAB | 33 |
| 4 | TREMELIMUMAB | 33 |
| 5 | ATEZOLIZUMAB | 32 |
| 6 | AMLODIPINE | 15 |
| 7 | ETOPOSIDE | 13 |
| 8 | FUROSEMIDE | 12 |
| 9 | SPIRONOLACTONE | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TREMELIMUMAB | 33 | 0.0075 |
| 1 | CASTOR OIL | 1 | 0.0052 |
| 2 | SORAFENIB | 44 | 0.0021 |
| 3 | ETHIODIZED OIL | 2 | 0.0015 |
| 4 | DURVALUMAB | 33 | 0.0015 |
| 5 | LENVATINIB | 50 | 0.0015 |
| 6 | TAURINE | 1 | 0.0013 |
| 7 | DACTINOMYCIN | 2 | 0.0009 |
| 8 | NICARDIPINE HYDROCHLORIDE | 2 | 0.0009 |
| 9 | LURBINECTEDIN | 1 | 0.0009 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Ligand-1 Blocker [EPC] | 33 | 0.0015 |
| 1 | Actinomycin [EPC] | 2 | 0.0009 |
| 2 | CTLA-4-directed Blocking Antibody [EPC] | 36 | 0.0007 |
| 3 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 4 | 0.0006 |
| 4 | Vasopressin V2 Receptor Antagonist [EPC] | 8 | 0.0005 |
| 5 | Bile Acid [EPC] | 11 | 0.0005 |
| 6 | Nitrogen Binding Agent [EPC] | 1 | 0.0004 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 39 | 0.0004 |
| 8 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 37 | 0.0002 |
| 9 | Kinase Inhibitor [EPC] | 96 | 0.0002 |